Author Lehmann, Sylvain

1 to 8 of 8 Items
  • 2012 Review
    ​ ​Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update​
    del Campo, M.; Mollenhauer, B.; Bertolotto, A.; Engelborghs, S.; Hampel, H.; Simonsen, A. H.& Kapaki, E. et al.​ (2012)
    Biomarkers in Medicine, 6​(4) pp. 419​-430​.​
    Future Medicine Ltd. DOI: https://doi.org/10.2217/BMM.12.46 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article | 
    ​ ​The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases​
    Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al.​ (2015) 
    Frontiers in Neurology6 art. UNSP 216​.​ DOI: https://doi.org/10.3389/fneur.2015.00216 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics​
    Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al.​ (2016) 
    Journal of Alzheimer's Disease52(1) pp. 51​-64​.​ DOI: https://doi.org/10.3233/jad-150883 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation​
    Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P.   & Lleó, A. et al.​ (2018) 
    Alzheimer's Research & Therapy10(1).​ DOI: https://doi.org/10.1186/s13195-018-0359-x 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease​
    Kruse, N.; Heslegrave, A.; Gupta, V.; Foiani, M.; Villar-Piqué, A.; Schmitz, M. & Lehmann, S. et al.​ (2018) 
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring10 pp. 461​-470​.​ DOI: https://doi.org/10.1016/j.dadm.2018.06.005 
    Details  DOI  PMID  PMC 
  • 2020 Journal Article
    ​ ​International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease​
    Delaby, C.; Teunissen, C. E; Alcolea, D.; Amar, E. B.; Beaume, A.; Bedel, A. & Bigot‐Corbel, E. et al.​ (2020) 
    Alzheimer's & Dementia16(S5).​ DOI: https://doi.org/10.1002/alz.047209 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study​
    Saddiki, H.; Fayosse, A.; Cognat, E.; Sabia, S.; Engelborghs, S.; Wallon, D. & Alexopoulos, P. et al.​ (2020) 
    PLoS Medicine17(8) pp. e1003289​.​ DOI: https://doi.org/10.1371/journal.pmed.1003289 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview​
    Delaby, C.; Teunissen, C. E.; Blennow, K.; Alcolea, D.; Arisi, I.; Amar, E. B. & Beaume, A. et al.​ (2021) 
    Alzheimer's & Dementia,.​ DOI: https://doi.org/10.1002/alz.12545 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page